New cancer clinical trial: A Multicenter Phase II/III-study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer (Affibody-3).

Published on: August 31, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share